ML17173A013: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
(3 intermediate revisions by the same user not shown)
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:June 22, 2017 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555 SMT-2017-031
{{#Wiki_filter:June 22, 2017                                                                                           SMT-2017-031 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555


==References:==
==References:==
 
(1) SHINE Medical Technologies, Inc. letter to NRC, "SHINE Medical Technologies, Inc. Request for Confirmation Related to a Proposed Demonstration Project," dated March 17, 2017 (ML17079A503)
(1) SHINE Medical Technologies, Inc. letter to NRC, "SHINE Medical Technologies, Inc. Request for Confirmation Related to a Proposed Demonstration Project,"
Supplement to SHINE Medical Technologies, Inc. Request for Confirmation Related to a Proposed Demonstration Project Via Reference (1 ), SHINE Medical Technologies, Inc. (SHINE) provided the NRC with a technical description of a proposed demonstration unit and a regulatory evaluation supporting the SHINE conclusion that the proposed demonstration unit does not meet the 10 CFR 50.2 definition of "utilization facility" for docket number 50-608. SHINE requested NRC staff confirmation that the proposed demonstration unit does not meet the 10 CFR 50.2 definition of "utilization facility" for docket number 50-608.
dated March 17, 2017 (ML 17079A503)
During a June 21 , 2017 phone call between SHINE and the NRC, the NRC requested supplemental information from SHINE regarding the expected enrichment of the uranium solution to be irradiated in the proposed demonstration unit. The enriched uranium solution to be irradiated in the proposed demonstration unit will use low enriched uranium (i.e., enriched to less than 20 wt.% 235 U).
Supplement to SHINE Medical Technologies, Inc. Request for Confirmation Related to a Proposed Demonstration Project Via Reference (1 ), SHINE Medical Technologies, Inc. (SHINE) provided the NRC with a technical description of a proposed demonstration unit and a regulatory evaluation supporting the SHINE conclusion that the proposed demonstration unit does not meet the 1 O CFR 50.2 definition of "utilization facility" for docket number 50-608. SHINE requested NRC staff confirmation that the proposed demonstration unit does not meet the 10 CFR 50.2 definition of "utilization facility" for docket number 50-608. During a June 21, 2017 phone call between SHINE and the NRC, the NRC requested supplemental information from SHINE regarding the expected enrichment of the uranium solution to be irradiated in the proposed demonstration unit. The enriched uranium solution to be irradiated in the proposed demonstration unit will use low enriched uranium (i.e., enriched to less than 20 wt.% 235U). If you have any questions, please contact me at 608/210-1735.
If you have any questions, please contact me at 608/210-1735.
Very truly yours, Jeff Bartelme Licensing Manager SHINE Medical Technologies, Inc. Docket No. 50-608 cc: Project Manager, USNRC Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health 101 E. Milwaukee St., Suite 600 I Janesville, WI 53545 IP (608) 210-1060 IF (608) 210-2504 I www.shinemed
Very truly yours, Jeff Bartelme Licensing Manager SHINE Medical Technologies, Inc.
.com}}
Docket No. 50-608 cc:       Project Manager, USNRC Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health 101 E. Milwaukee St., Suite 600 I Janesville, WI 53545 IP (608) 210-1060 IF (608) 210-2504 I www.shinemed.com}}

Latest revision as of 11:19, 10 November 2019

Supplement to Shine Medical Technologies, Inc. Request for Confirmation Related to a Proposed Demonstration Project
ML17173A013
Person / Time
Site: SHINE Medical Technologies
Issue date: 06/22/2017
From: Bartelme J
SHINE Medical Technologies
To:
Document Control Desk, Office of Nuclear Reactor Regulation
References
SMT-2017-031
Download: ML17173A013 (1)
v • d • e


Text

June 22, 2017 SMT-2017-031 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555

References:

(1) SHINE Medical Technologies, Inc. letter to NRC, "SHINE Medical Technologies, Inc. Request for Confirmation Related to a Proposed Demonstration Project," dated March 17, 2017 (ML17079A503)

Supplement to SHINE Medical Technologies, Inc. Request for Confirmation Related to a Proposed Demonstration Project Via Reference (1 ), SHINE Medical Technologies, Inc. (SHINE) provided the NRC with a technical description of a proposed demonstration unit and a regulatory evaluation supporting the SHINE conclusion that the proposed demonstration unit does not meet the 10 CFR 50.2 definition of "utilization facility" for docket number 50-608. SHINE requested NRC staff confirmation that the proposed demonstration unit does not meet the 10 CFR 50.2 definition of "utilization facility" for docket number 50-608.

During a June 21 , 2017 phone call between SHINE and the NRC, the NRC requested supplemental information from SHINE regarding the expected enrichment of the uranium solution to be irradiated in the proposed demonstration unit. The enriched uranium solution to be irradiated in the proposed demonstration unit will use low enriched uranium (i.e., enriched to less than 20 wt.% 235 U).

If you have any questions, please contact me at 608/210-1735.

Very truly yours, Jeff Bartelme Licensing Manager SHINE Medical Technologies, Inc.

Docket No. 50-608 cc: Project Manager, USNRC Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health 101 E. Milwaukee St., Suite 600 I Janesville, WI 53545 IP (608) 210-1060 IF (608) 210-2504 I www.shinemed.com

Retrieved from "https://kanterella.com/w/index.php?title=ML17173A013&oldid=2082585"